Born in Naples on 6 July 1970 and obtained a degree in Biological Sciences from the Federico II University of Naples. PhD in Clinical Pathology, at the Federico II University Polyclinic of Naples, he began his career in 1997, at Cirio researching “Production of lactose-free milk for lactose intolerant subjects” for the CNR of Naples. Since 2003 at the Pascale Cancer Institute of Naples, under the direction of Prof. Paolo Ascierto, post-therapy evaluation of tumor immunosuppression in patients suffering from advanced neoplasia” National Institute for the study and treatment of tumors “Giovanni Pascale Foundation “In collaboration with the CROM and CNR of Avellino, he continues his research path on melanoma and epidemiological investigations on nutrition” Project on nutrition education in middle schools of Sperone (AV) for the CROM of Avellino” with over 30 publications to his credit National and International names, some of which in his first name. Since 2006 he has chosen to work as a freelancer in the nutrition sector at his Nutrition & Wellbeing centre, located in Casoria in via Leonardo Da Vinci 32, where as director of aesthetics he carries out an aesthetic complement to the nutritional and research one, and also collaborates with various professionals, following paths nutritional ranging from childhood to senile age, to aesthetic medicine. From 2011-2013 with the Mo.DAVI Onlus school project – Lifestyle and correct nutrition in secondary schools in Campania. It also makes use of the oxidative stress analysis, which is performed at the Federico II in Naples, in order to develop antioxidant diets. In addition to having her center in Casoria, the doctor practices her profession in various medical practices scattered throughout Italy, from the Calabria region to Tuscany and Veneto. Since 2015 she has become a publicist for various online newspapers, until obtaining in 2020, the journalist title.
October 3, 2024
Alignment Health Plan expands provider network with Intermountain Health, improving access to care in Nevada
Alignment Health Plan announced it is expanding access to high-quality health care and services for its policyholders in Clark and Washoe counties through a new agreement with Intermountain Health. Beginning January 1, 2025, the agreement will offer Alignment Nevada policyholders access to more than 65 clinics in the Silver State, 35 of which are designated senior primary care clinics. Medicare-eligible residents of Clark and Washoe counties who enroll in Alignment during the annual enrollment period, October 15 through December 7, can benefit from all of Intermountain’s services, including primary, specialty and urgent care services at starting from 1 January 2025.
In these counties, Alignment offers four HMO options, including a special needs plan for policyholders with qualifying chronic heart conditions and diabetes, a special needs plan for policyholders enrolled in both Medicare and Medicaid, and its Platinum+ plan Instacart (HMO), which earned a 5-star rating from the Centers for Medicare & Medicaid Services (CMS) in 2024. Each year, CMS evaluates plans based on a 5-star rating, with 5 stars representing “excellent” performance “.
Star ratings for the 2025 plan year are expected to be announced in mid-October.
OpenAI: obtains $4 billion credit line, total liquidity over $10 billion
(Il Sole 24 Ore Radiocor) – Milan, 03 Oct – OpenAI has obtained a revolving credit line of 4 billion dollars from major financial institutions such as JPMorgan Chase, Citi, Goldman Sachs, Morgan Stanley, Santander, Wells Fargo, Smbc, Ubs and Hsbc. This deal brings the company’s overall liquidity to over $10 billion. The credit line has a base of 4 billion, with the possibility of increasing it by another 2 billion, and will remain available for a period of three years. According to information gathered by CNBC, the loan is unsecured and the interest rate applied will be equal to the Sofr rate (currently above 5%) plus 100 basis points, which means that OpenAI will pay around 6% on the borrowed funds . This funding comes after a fundraising round that valued OpenAI at $157 billion and during which it raised $6.6 billion from a large group of investors. These include Thrive Capital, which invested 1 billion, Microsoft, Nvidia, SoftBank, Khosla Ventures, Altimeter Capital, Fidelity Management & Research Company, Mgx and Tiger Global. The new funds will allow OpenAI to expand its infrastructure, invest in research and development of new products, as well as attract new talent to support growth. In a blog post, OpenAI highlighted the importance of the financial flexibility offered by this agreement, which will allow the company to operate nimbly as it expands. It also strengthened its relationships with participating financial institutions, many of which are also OpenAI customers.
Com-Cop
(RADIOCOR) 03-10-24 16:47:55 (0552) 3 NNNN
(END) Dow Jones Newswires
October 03, 2024 10:48 ET (14:48 GMT)
Question from Ms. LASSARADE Florence (Gironde – Les Républicains) published on 03/10/2024
Ms. Florence Lassarade draws the attention of the Minister of Health and Access to Care to the treatment of mucositis by phototherapy. Mucositis is a painful inflammation of the mucous membranes, which can occur in the mouth (oral mucositis) or the gastrointestinal tract. It is often a complication of cancer treatments such as chemotherapy and radiotherapy. Oral mucositis is characterized by ulcers and pain in the mouth, making nutrition and hydration difficult for patients. Photobiomodulation uses low-power lasers or light-emitting diodes (LEDs) to stimulate tissue repair and reduce inflammation and pain. This non-invasive treatment is effective in the treatment of mucositis induced by chemotherapy and radiotherapy. Numerous clinical studies have in fact shown that phototherapy can reduce the incidence, severity and duration of mucositis in patients receiving chemotherapy or radiotherapy. Therefore, it is increasingly recommended as a preventive and therapeutic treatment. To the extent that the use of photobiomodulation can significantly improve the quality of life of patients by reducing pain and inflammation and accelerating the healing of damaged tissues, she would like to know whether the Government is considering authorizing reimbursement for this treatment by social security.
Published in the OJ Senate of 03/10/2024 – page 3587